Low malignant potential ovarian tumours: A review of 175 consecutive cases

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 37, Issue 1, 1997, Pages 100-103

  Buttini, Melissa ^a,b   Nickiin, James L ^a,c   Crandon, Alex ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

^c WESLEY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PLATINUM;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; AUSTRALIA; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONSERVATIVE TREATMENT; EPITHELIUM TUMOR; FEMALE; FOLLOW UP; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; OVARY TUMOR; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031040395     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.1997.tb02228.x     Document Type: Article

References (16)

1. Leake JF, Currie JL, Rosenshein NB, Woodruff JD. Long term follow up of serous ovarian tumors of low malignant potential. Gynecol Oncol 1992; 47: 150-158.
2. Casey AC, Bell DA, Lage JM, Fuller AF, Nikrui N, Rice LW. Epithelial ovarian tumours of borderline malignancy: long-term follow-up. Gynecol Oncol 1993; 50: 316-322.
3. Rice LW, Berkowitz RS, Mark SD, Yavner DL, Lage JM. Epithelial ovarian tumours of borderline malignancy. Gynecol Oncol 1990; 39: 195-198.
4. Barnhill D, Heller P, Brzozowski P, Advani H, Gallup D, Park R. Epithelial ovarian carcinoma of low malignant potential. Obstet Gynecol 1985; 65: 53-59.
5. Trope C, Kaern J, Vergote IB, Kristensen G, Abeler V. Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors. Gynecol Oncol 1993; 51: 236-243.
6. Gershenson DM, Silva EG. Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer 1990; 65. 578-585.
7. Kaern J, Trope CG, Abeler VM. A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities. Cancer 1993; 71: 1810-1820.
8. Bostwick DG, Tazelaar HD, Ballon SC, Hendrickson MR, Kempson RL. Ovarian epithelial tumors of borderline malignancy. A clinical and pathologic study of 109 cases. Cancer 1986; 58: 2052-2065.
9. Tazelaar HD, Bostwick DG, Ballon SC, Hendrickson MR, Kempson RL. Conservative treatment of borderline ovarian tumors. Obstet Gynecol 1985; 66: 417-422.
10. Lim-Tan SK, Cajigas HE, Scully RE. Ovarian cystectomy for serous borderline tumors: a follow up study of 35 cases. Obstet Gynecol 1988; 72: 775-781.
11. Snider DD, Stuart GC, Nation JG, Robertson DI. Evaluation of surgical staging in stage 1 low malignant potential ovarian tumors. Gynecol Oncol 1991; 40: 129-132.
12. Leake JF, Rader JS, Woodruff MD, Rosenshein NB. Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1991; 42: 124-130.
13. Michael H, Roth LM. Invasive and noninvasive implants in ovarian serous tumours of low malignant potential. Cancer 1986; 57: 1240-1247.
14. Fort MG, Pierce VK, Saigo PE, Hoskins WJ, Lewis JL Jr. Evidence for the efficacy of adjuvant therapy in epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1989; 32: 269-272.
15. Sutton GP, Bundy BN, Omura GA, Yordan EL, Beecham JB, Bonfiglio T. Stage III ovarian tumours of low malignant potential treated with cisplatin combination therapy (A Gynecologic Oncology Group Study). Gynecol Oncol 1991; 41: 230-233.
16. NIH Consensus Conference. Ovarian Cancer. Screening, treatment and follow-up. JAMA 1995; 273: 491-497.